Blue Water Life Science Advisors, LP Adaptive Biotechnologies Corp Transaction History
Blue Water Life Science Advisors, LP
- $101 Million
- Q1 2025
A detailed history of Blue Water Life Science Advisors, LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 2,145,145 shares of ADPT stock, worth $26.2 Million. This represents 15.79% of its overall portfolio holdings.
Number of Shares
2,145,145
Previous 2,145,145
-0.0%
Holding current value
$26.2 Million
Previous $12.9 Million
23.84%
% of portfolio
15.79%
Previous 11.71%
Shares
9 transactions
Others Institutions Holding ADPT
# of Institutions
254Shares Held
152MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$366 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$160 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$136 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$81 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.74B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...